SaAWangMD

PubMed

• Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.
  Wei-Ying Jen, Wei Qiao, Farhad Ravandi, Koji Sasaki, Sanam Loghavi, Sa A Wang, Gautam Borthakur, Tapan M Kadia, Ghayas C Issa, Nicholas J Short, Musa Yilmaz, Naval G D...> ;British Journal of Haematology. 2024 Apr 11
• Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.
  Genevieve M Crane, Julia T Geyer, Beenu Thakral, Sa A Wang, Geoffrey D Wool, Ke David Li, Adam R Davis, Leonardo Boiocchi, David Bosler, Carlos E Bueso-Ramos, Daniel A...> ;American Journal of Clinical Pathology. 2024 Apr 10
• Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma.
  Fnu Sameeta, Hong Fang, Wei Wang, Zhenya Tang, Sa A Wang, Gokce A Toruner, Xenia Parisi, Joseph D Khoury, Ghayas Issa, Guillermo Garcia-Manero, L Jeffrey Medeiros, Gui...> ;American Journal of Hematology. 2024 Mar 5
• Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents.
  Marques-Piubelli, M., Kumar, B., Basar, R., Panowski, S., Srinivasan, S., Norwood, K., Prashad, S., Szenes, V., Balakumaran, A., Arandhya, A., Lu, W., Khan, K., Duenas...> ;Virchows Archiv. 2024 Feb 22
• Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis.
  Medeiros, L., Nwogbo, O., Fang, H., Wang, W., Xu, J., Miranda, R., Bose, P., Ok, C., Jorgensen, J., Wang, S.> ;American Journal of Clinical Pathology. 2024 Feb 19
• 2 citations
  Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission.
  Fadi G Haddad, Nicholas J Short, Jayastu Senapati, Nitin Jain, Koji Sasaki, Yesid Alvarado, Xuemei Wang, Lucia Masarova, Farhad Ravandi, Elias Jabbour, Jeffrey Jorgens...> ;Blood. 2024 Feb 1
• Non-V600Emutation in hairy cell leukemia variant.
  Medeiros, L., Vijayanarayanan, A., Wang, S., Garces, S., Saluja, K., Thakral, B.> ;Ejhaem. 2024 Feb 1
• Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.
  Zhou, T., Curry, C., Khanlari, M., Shi, M., Cui, W., Peker, D., Chen, W., Wang, E., Gao, J., Shen, Q., Xie, W., Jelloul, F., King, R., Yuan, J., Wang, X., Zhao, C., Ob...> ;Blood Cancer Journal. 2024 Jan 25
• 2 citations
  mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
  C Cameron Yin, Wayne Tam, Serena M Walker, Amandeep Kaur, Madhu M Ouseph, Wei Xie, Olga K Weinberg, Peng Li, Zhuang Zuo, Mark J Routbort, Simon Chen, L Jeffrey Medeiro...> ;Haematologica. 2023 Nov 16
• 1 citations
  Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.
  Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan M Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas J Short, Koji Sasak...> ;Blood Cancer Journal. 2023 Sep 21
• Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation.
  Shuyu E, Karen A Nahmod, Sa A Wang, C Cameron Yin> ;International Journal of Laboratory Hematology. 2024 Feb 1
• Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
  Tapan M Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval Daver, Elias Jabbour, Courtney D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra...> ;American Journal of Hematology. 2023 Nov 1
• 3 citations
  Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection.
  Sa A Wang, Jeffrey L Jorgensen, Shimin Hu, Fuli Jia, Shaoying Li, Sanam Loghavi, Chi Young Ok, Beenu Thakral, Jie Xu, L Jeffrey Medeiros, Wei Wang> ;Cytometry. Part B, Clinical Cytometry. 2023 Sep 1
• Persistent polyclonal B-cell lymphocytosis with buttock-like cells mimicking follicular lymphoma.
  Fnu Aakash, Sa A Wang, Karan Saluja, Beenu Thakral> ;Blood Research. 2023 Sep 30
• 1 citations
  T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.
  Hong Fang, Hannah C Beird, Sa A Wang, Andrew F Ibrahim, Zhenya Tang, Guilin Tang, M James You, Shimin Hu, Jie Xu, Shaoying Li, C Cameron Yin, Siba El Hussein, Nhi Le, ...> ;Leukemia. 2023 Sep 1
• Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.
  Kathryn Foucar, Adam Bagg, Carlos E Bueso-Ramos, Tracy George, Robert P Hasserjian, Eric D Hsi, Attilio Orazi, Wayne Tam, Sa A Wang, Olga K Weinberg, Daniel A Arber> ;American Journal of Clinical Pathology. 2023 Oct 3
• 10 citations
  The international consensus classification of eosinophilic disorders and systemic mastocytosis.
  Sa A Wang, Attilio Orazi, Jason Gotlib, Andreas Reiter, Alexandar Tzankov, Robert P Hasserjian, Daniel A Arber, Ayalew Tefferi> ;American Journal of Hematology. 2023 Aug 1
• Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
  Corinn Small, Soham Mukerjee, Diwash Jangam, Sumanth Gollapudi, Kunwar Singh, David L Jaye, Phyu P Aung, Christiane Querfeld, Keluo Yao, Karen M Chisholm, Sheeja Pulla...> ;International Journal of Laboratory Hematology. 2023 Oct 1
• 16 citations
  Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell...
  Elias Jabbour, Nicholas J Short, Jayastu Senapati, Nitin Jain, Xuelin Huang, Naval Daver, Courtney D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia-Manero...> ;The Lancet. Haematology. 2023 Jun 1
• 1 citations
  Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Patho...
  Timothy Kirtek, Weina Chen, Dorottya Laczko, Adam Bagg, Prasad Koduru, Kathryn Foucar, Elise Venable, Meredith Nichols, Heesun J Rogers, Wayne Tam, Attilio Orazi, Eric...> ;Leukemia Research. 2023 Jul 1
• 2 citations
  DDX41 mutations in patients with non-myeloid hematologic neoplasms.
  Fatima Zahra Jelloul, Mark J Routbort, Courtney D DiNardo, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, Beenu Thakral, Zhuang Zuo, C Cameron Yin, Sanam Loghavi, Chi ...> ;American Journal of Hematology. 2023 Aug 1
• 2 citations
  Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD.
  Philip A Thompson, Michael J Keating, Alessandra Ferrajoli, Nitin Jain, Christine B Peterson, Naveen Garg, Sa A Wang, Jeffrey L Jorgensen, Tapan M Kadia, Prithviraj Bo...> ;Leukemia. 2023 Jul 1
• Issue highlights-May 2023.
  Sa Wang> ;Cytometry. Part B, Clinical Cytometry. 2023 May 1
• 2 citations
  Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements.
  Siddiqui, M., Konoplev, S., Issa, G., Kantarjian, H., Daver, N., Ravandi, F., Kadia, T., Tang, G., Wang, S., Thakral, B., Medeiros, L., Pozdnyakova, O., Pierce, S., Mo...> ;American Journal of Hematology. 2023 Apr 1
• 8 citations
  Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity.
  Alexandre Bazinet, Tapan Kadia, Nicholas J Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey Jorgensen, Keyur Patel, Courtney DiNardo, Naval Daver, ...> ;Blood Advances. 2023 Jul 11
• Join now to see all

Journal Articles

• Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter Study  
  Guilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature
• CD123 Expression Patterns and Selective Targeting with a CD123-Specific Antibody-Drug Conjugate (IMGN632) in Acute Lymphoblastic Leukemia  
  L Jeffrey Medeiros, Hagop M Kantarjian, Jeffrey L Jorgensen, Marina Konopleva, Elias J Jabbour, Joseph D Khoury, Sa A Wang, Sergej N Konoplev, Haematologica
• T-cell Prolymphocytic Leukemia Negative for Surface CD3 and CD45  
  Sa Wang, MD, Blood

Abstracts/Posters

• Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Achievement of Complete Remission (CR) with Measurable Residual Disease (MRD) Negativity Is Highly Prognostic in Patients (pts) with Relapsed or Refractory (R/R) Acute...
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes in Molecular Subgroups and Resistance Patterns with Ten-Day Decitabine and Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Phase II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (B-ALL) with Positive Measurable Residual Disease (MRD)
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax Regimens
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (iFCG) for First-Line Treatment of IGHV-Mutated CLL and without Del(17p)/Mutated TP53
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcome of Patients (Pts) with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) without 3-Month Complete Molecular Response (CMR)
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Results of a Phase II TrialClinically Relevant Abstract
  Sa A Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018